$ALIM Recent Headlines Top longs and shorts to w
Post# of 94146
Posted On: 12/12/2013 9:36:30 AM
$ALIM Recent Headlines
Top longs and shorts to watch 12:18 p.m. March 6, 2012 - The Trading Deck
Tuesday’s biggest gaining and declining stocks 5:37 p.m. Feb. 28, 2012 - Kate Gibson
Friday’s biggest gaining and declining stocks 6:06 p.m. Nov. 11, 2011 - Kate Gibson
Monday’s biggest gaining and declining stocks 5:30 p.m. Dec. 27, 2010 - Kate Gibson
Alimera, pSivida slammed by FDA move 2:30 p.m. Dec. 27, 2010 - Val Brickates Kennedy
Alimera, pSivida crushed by FDA setback 9:36 a.m. Dec. 27, 2010 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 3:48 p.m. Aug. 31, 2010 - MarketWatch
Alimera, pSivida, Bayer lead drug-stock rally 12:15 p.m. Aug. 31, 2010 - Val Brickates Kennedy
Alimera leads drug stocks higher 9:21 a.m. Aug. 31, 2010 - Val Brickates Kennedy
Alimera Sciences shares jump 9.3% on FDA move 8:34 a.m. Aug. 31, 2010 - Laura Mandaro
Alimera jumps on FDA update 8:28 a.m. Aug. 31, 2010 - Val Brickates Kennedy
Javelin rockets as drug stocks head south 2:41 p.m. June 29, 2010 - Val Brickates Kennedy
Three tech companies highlight busy IPO day 4:30 p.m. April 22, 2010 - Benjamin Pimentel
Baxter, Affymetrix lead drug stocks lower 1:05 p.m. April 22, 2010 - Val Brickates Kennedy
Final Guidance from NICE for pSivida's Iluvien - Analyst Blog 5:00 p.m. Dec. 5, 2013 - Zacks.com
Iluvien, Lucentis get NICE nod 9:38 a.m. Nov. 27, 2013 - Seeking Alpha
Ampio Hides Need For New Eye Drug Study in SEC Filing 8:03 a.m. Nov. 25, 2013 - TheStreet.com
Alimera Sciences Inc. is now in Oversold Territory - Tale of the Tape 8:48 a.m. Nov. 15, 2013 - Zacks.com
10-Q: ALIMERA SCIENCES INC 9:14 a.m. Nov. 13, 2013 - Edgar Online - (EDG = 10Q, 10K)
Alimera Sciences Management Discusses Q3 2013 Results - Earnings Call Transcript 6:40 p.m. Nov. 11, 2013 - Seeking Alpha
Alimera Down on 3rd Iluvien CRL - Analyst Blog 5:10 p.m. Oct. 21, 2013 - Zacks.com
PSivida: Thoughts In The Aftermath Of The Complete Response Letter On Iluvien 4:13 p.m. Oct. 20, 2013 - Seeking Alpha
pSivida, Alimera and Ariad Join Bio-Implosion Watch 7:52 a.m. Oct. 18, 2013 - 247WallSt.com
Alimera Sciences Receives FDA CRL for ILUVIEN 4:31 a.m. Oct. 18, 2013 - benzinga.com
PSivida: Previewing The Possible Effect On The Stock Of The October 17th PDUFA Date For Iluvien 6:57 p.m. Oct. 7, 2013 - Seeking Alpha
pSivida Corporation: Strong Takeover Target, October 17th PDUFA Date Make It A Buy 3:00 a.m. Oct. 7, 2013 - Seeking Alpha
Five FDA Approvals and Reviews at Risk Under a Government Shutdown 8:49 a.m. Sept. 30, 2013 - 247WallSt.com
A Closer Look At PSivida's Pipeline 4:31 p.m. Sept. 16, 2013 - Seeking Alpha
5 Pharmaceutical Stocks to Buy Now 7:45 a.m. Aug. 30, 2013 - InvestorPlace.com
10-Q: ALIMERA SCIENCES INC 6:03 p.m. Aug. 14, 2013 - Edgar Online - (EDG = 10Q, 10K)
Alimera Sciences Management Discusses Q2 2013 Results - Earnings Call Transcript 5:10 p.m. Aug. 12, 2013 - Seeking Alpha
Keep An Eye On ICo Therapeutics 10:47 a.m. July 29, 2013 - Seeking Alpha
France's Transparency Commission Issues Positive Opinion For Reimbursement Of ILUVIEN® 5:35 a.m. July 24, 2013 - benzinga.com
pSivida Up on Phase I/II Interim Data - Analyst Blog 4:10 p.m. July 16, 2013 - Zacks.com
U.K.'s NICE Issues Final Guidance Recommending Alimera Sciences' ILUVIEN® 7:00 a.m. Dec. 2, 2013 - PR Newswire
Alimera Sciences Reports Third Quarter 2013 Financial Results 4:05 p.m. Nov. 11, 2013 - PR Newswire
Alimera Sciences to Release Third Quarter 2013 Results and Provide Update on Upcoming FDA Advisory Committee Meeting 5:30 a.m. Oct. 31, 2013 - PR Newswire
pSivida Reports Complete Response Letter From FDA for ILUVIEN(R) 5:33 a.m. Oct. 18, 2013 - BusinessWire
Alimera Sciences Receives Complete Response Letter For ILUVIEN® 5:30 a.m. Oct. 18, 2013 - PR Newswire
U.K.'s NICE Issues Final Appraisal Determination Recommending Alimera's ILUVIEN® for Chronic Diabetic Macular Edema 6:01 p.m. Sept. 30, 2013 - PR Newswire
Alimera Sciences Reports Second Quarter 2013 Financial Results 3:05 p.m. Aug. 12, 2013 - PR Newswire
Alimera Sciences to Release Second Quarter Fiscal Year 2013 Financial Results 3:05 p.m. Aug. 5, 2013 - PR Newswire
France's Transparency Commission Issues Positive Opinion For Reimbursement Of ILUVIEN? 6:30 a.m. July 24, 2013 - PR Newswire
Alimera Sciences Added To Russell 2000?, 3000? And Global Indexes 5:30 a.m. July 1, 2013 - PR Newswire
Alimera Sciences Announces Issuance Of A Positive Appraisal Recommendation On ILUVIEN? For Consultation In The United Kingdom 5:30 a.m. June 14, 2013 - PR Newswire
pSivida Corp President and CEO, Dr. Paul Ashton Publishes New Blog Entitled ''Big and Small Picture'' 7:30 a.m. May 23, 2013 - ACCESSWIRE
pSivida Corp. Reports Third Quarter Fiscal Year 2013 Results 3:00 p.m. May 13, 2013 - BusinessWire
Alimera Sciences Reports First Quarter 2013 Financial Results 3:05 p.m. May 9, 2013 - PR Newswire
Alimera Sciences Secures $20 Million Debt Facility 7:00 a.m. May 8, 2013 - PR Newswire
pSivida Corp. Announces Commercial Launch of ILUVIEN(R) in Germany with First Patient Treated 3:14 p.m. May 7, 2013 - BusinessWire
Alimera Sciences Announces First Patient Treated With Commercially Available ILUVIEN? 3:01 p.m. May 7, 2013 - PR Newswire
Alimera Sciences To Release First Quarter Fiscal Year 2013 Financial Results 12:20 p.m. May 3, 2013 - PR Newswire
pSivida Corp. Announces New ILUVIEN(R) PDUFA Date of October 17, 2013 7:01 a.m. May 1, 2013 - BusinessWire
Alimera Sciences Announces New PDUFA Date For ILUVIEN? 7:00 a.m. May 1, 2013 - PR Newswire
Top longs and shorts to watch 12:18 p.m. March 6, 2012 - The Trading Deck
Tuesday’s biggest gaining and declining stocks 5:37 p.m. Feb. 28, 2012 - Kate Gibson
Friday’s biggest gaining and declining stocks 6:06 p.m. Nov. 11, 2011 - Kate Gibson
Monday’s biggest gaining and declining stocks 5:30 p.m. Dec. 27, 2010 - Kate Gibson
Alimera, pSivida slammed by FDA move 2:30 p.m. Dec. 27, 2010 - Val Brickates Kennedy
Alimera, pSivida crushed by FDA setback 9:36 a.m. Dec. 27, 2010 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 3:48 p.m. Aug. 31, 2010 - MarketWatch
Alimera, pSivida, Bayer lead drug-stock rally 12:15 p.m. Aug. 31, 2010 - Val Brickates Kennedy
Alimera leads drug stocks higher 9:21 a.m. Aug. 31, 2010 - Val Brickates Kennedy
Alimera Sciences shares jump 9.3% on FDA move 8:34 a.m. Aug. 31, 2010 - Laura Mandaro
Alimera jumps on FDA update 8:28 a.m. Aug. 31, 2010 - Val Brickates Kennedy
Javelin rockets as drug stocks head south 2:41 p.m. June 29, 2010 - Val Brickates Kennedy
Three tech companies highlight busy IPO day 4:30 p.m. April 22, 2010 - Benjamin Pimentel
Baxter, Affymetrix lead drug stocks lower 1:05 p.m. April 22, 2010 - Val Brickates Kennedy
Final Guidance from NICE for pSivida's Iluvien - Analyst Blog 5:00 p.m. Dec. 5, 2013 - Zacks.com
Iluvien, Lucentis get NICE nod 9:38 a.m. Nov. 27, 2013 - Seeking Alpha
Ampio Hides Need For New Eye Drug Study in SEC Filing 8:03 a.m. Nov. 25, 2013 - TheStreet.com
Alimera Sciences Inc. is now in Oversold Territory - Tale of the Tape 8:48 a.m. Nov. 15, 2013 - Zacks.com
10-Q: ALIMERA SCIENCES INC 9:14 a.m. Nov. 13, 2013 - Edgar Online - (EDG = 10Q, 10K)
Alimera Sciences Management Discusses Q3 2013 Results - Earnings Call Transcript 6:40 p.m. Nov. 11, 2013 - Seeking Alpha
Alimera Down on 3rd Iluvien CRL - Analyst Blog 5:10 p.m. Oct. 21, 2013 - Zacks.com
PSivida: Thoughts In The Aftermath Of The Complete Response Letter On Iluvien 4:13 p.m. Oct. 20, 2013 - Seeking Alpha
pSivida, Alimera and Ariad Join Bio-Implosion Watch 7:52 a.m. Oct. 18, 2013 - 247WallSt.com
Alimera Sciences Receives FDA CRL for ILUVIEN 4:31 a.m. Oct. 18, 2013 - benzinga.com
PSivida: Previewing The Possible Effect On The Stock Of The October 17th PDUFA Date For Iluvien 6:57 p.m. Oct. 7, 2013 - Seeking Alpha
pSivida Corporation: Strong Takeover Target, October 17th PDUFA Date Make It A Buy 3:00 a.m. Oct. 7, 2013 - Seeking Alpha
Five FDA Approvals and Reviews at Risk Under a Government Shutdown 8:49 a.m. Sept. 30, 2013 - 247WallSt.com
A Closer Look At PSivida's Pipeline 4:31 p.m. Sept. 16, 2013 - Seeking Alpha
5 Pharmaceutical Stocks to Buy Now 7:45 a.m. Aug. 30, 2013 - InvestorPlace.com
10-Q: ALIMERA SCIENCES INC 6:03 p.m. Aug. 14, 2013 - Edgar Online - (EDG = 10Q, 10K)
Alimera Sciences Management Discusses Q2 2013 Results - Earnings Call Transcript 5:10 p.m. Aug. 12, 2013 - Seeking Alpha
Keep An Eye On ICo Therapeutics 10:47 a.m. July 29, 2013 - Seeking Alpha
France's Transparency Commission Issues Positive Opinion For Reimbursement Of ILUVIEN® 5:35 a.m. July 24, 2013 - benzinga.com
pSivida Up on Phase I/II Interim Data - Analyst Blog 4:10 p.m. July 16, 2013 - Zacks.com
U.K.'s NICE Issues Final Guidance Recommending Alimera Sciences' ILUVIEN® 7:00 a.m. Dec. 2, 2013 - PR Newswire
Alimera Sciences Reports Third Quarter 2013 Financial Results 4:05 p.m. Nov. 11, 2013 - PR Newswire
Alimera Sciences to Release Third Quarter 2013 Results and Provide Update on Upcoming FDA Advisory Committee Meeting 5:30 a.m. Oct. 31, 2013 - PR Newswire
pSivida Reports Complete Response Letter From FDA for ILUVIEN(R) 5:33 a.m. Oct. 18, 2013 - BusinessWire
Alimera Sciences Receives Complete Response Letter For ILUVIEN® 5:30 a.m. Oct. 18, 2013 - PR Newswire
U.K.'s NICE Issues Final Appraisal Determination Recommending Alimera's ILUVIEN® for Chronic Diabetic Macular Edema 6:01 p.m. Sept. 30, 2013 - PR Newswire
Alimera Sciences Reports Second Quarter 2013 Financial Results 3:05 p.m. Aug. 12, 2013 - PR Newswire
Alimera Sciences to Release Second Quarter Fiscal Year 2013 Financial Results 3:05 p.m. Aug. 5, 2013 - PR Newswire
France's Transparency Commission Issues Positive Opinion For Reimbursement Of ILUVIEN? 6:30 a.m. July 24, 2013 - PR Newswire
Alimera Sciences Added To Russell 2000?, 3000? And Global Indexes 5:30 a.m. July 1, 2013 - PR Newswire
Alimera Sciences Announces Issuance Of A Positive Appraisal Recommendation On ILUVIEN? For Consultation In The United Kingdom 5:30 a.m. June 14, 2013 - PR Newswire
pSivida Corp President and CEO, Dr. Paul Ashton Publishes New Blog Entitled ''Big and Small Picture'' 7:30 a.m. May 23, 2013 - ACCESSWIRE
pSivida Corp. Reports Third Quarter Fiscal Year 2013 Results 3:00 p.m. May 13, 2013 - BusinessWire
Alimera Sciences Reports First Quarter 2013 Financial Results 3:05 p.m. May 9, 2013 - PR Newswire
Alimera Sciences Secures $20 Million Debt Facility 7:00 a.m. May 8, 2013 - PR Newswire
pSivida Corp. Announces Commercial Launch of ILUVIEN(R) in Germany with First Patient Treated 3:14 p.m. May 7, 2013 - BusinessWire
Alimera Sciences Announces First Patient Treated With Commercially Available ILUVIEN? 3:01 p.m. May 7, 2013 - PR Newswire
Alimera Sciences To Release First Quarter Fiscal Year 2013 Financial Results 12:20 p.m. May 3, 2013 - PR Newswire
pSivida Corp. Announces New ILUVIEN(R) PDUFA Date of October 17, 2013 7:01 a.m. May 1, 2013 - BusinessWire
Alimera Sciences Announces New PDUFA Date For ILUVIEN? 7:00 a.m. May 1, 2013 - PR Newswire
(0)
(0)Scroll down for more posts ▼